Followers | 17 |
Posts | 936 |
Boards Moderated | 0 |
Alias Born | 04/26/2010 |
Friday, September 04, 2020 7:57:34 AM
How does SARS-CoV-2 virus enter human cells?
It is known that cell entry by the coronavirus requires the binding of the S1 region of the virus spike (S) protein to the cell surface receptor followed by the fusion of the viral and cellular membranes mediated by the S2 subunit of S protein. This process requires S protein priming by host cell proteases, which entails S protein cleavage at the boundary of S1 and S2 proteins or within the S2 subunit. SARS-CoV-2 utilizes angiotensin-converting enzyme 2 (ACE2) as cell entry receptor and transmembrane serine protease 2 (TMPRSS2) and/or the endosomal cysteine proteases cathepsin B and L (CatB/L) for S protein priming. It is thought that TMPRSS2 activity is essential for viral spread. Alveolar type 2 cells in lungs highly express both ACE2 and TMPRSS2.
The above is probably no news for most people around here. Well, here comes the distressing part of my findings. It turns out that SARS-CoV-2 can utilized some other receptors for entry, although using ACE2 remains the most efficient entry method. Among alternate entries are CD209 and CD209L. CD209L is expressed in lung and kidney epithelial cells and in endothelial cells of small and medium-sized vessels. Then there seems to be cell entry methods utilizing Neuropilin receptors and CD147/Basigin receptor. Note to male readers: CD147 is important in spermatogenesis and its presence in entry point list may explain why SARS-CoV-2 has been found in testes.
I occurred to me that any single inhibitor or receptor blocker needs be to amazingly talented if it intends to be successful. I would say that preventing SARS-CoV-2 cell entry will require quite a cocktail of antivirals. And I am talking only about cell entry. What happens after entry is another story.
It might be better if we had a treatment that would outright kill the virus instead of trying to inhibit or block. Has anybody around here heard of this kind of drug? It would be helpful if it is already proven to be safe in humans.
For additional reading:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407648/
"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM